Chicago Tribune |
CardioMEMS Heart Failure Device Gets Mixed Reception From FDA Advisory …
Forbes The FDA’s Circulatory System Devices Panel sent a mixed message to the FDA today about CardioMEMS Champion HF Pressure Measurement System. The small implantable device provides provides daily pulmonary artery pressure measurements to guide … Pulmonary Artery Monitor Gets FDA Panel BackingMedPage Today FLASH: FDA panel issues mixed vote on CardioMEMs Champion deviceMass Device |
Weight-Loss Supplement Tied to Liver Failure Cases – WebMD
Weight-Loss Supplement Tied to Liver Failure CasesWebMDHealth care providers, public health agencies and emergency departments should watch for patients who develop acute hepatitis or liver failure after they use a weight-loss or muscle-building dietar…
Bihar's government hospitals in districts to treat heart patients – Times of India
|
Bihar’s government hospitals in districts to treat heart patients
Times of India PATNA: All district hospitals in the state will have basic facilities for treatment of heart patients. In the first phase, 17 district hospitals will have intensive care units (ICUs) for the heart patients by October end and the remaining districts by … |
Supplement OxyElite Pro linked to liver failure, hepatitis – New York Daily News
New York Daily NewsSupplement OxyElite Pro linked to liver failure, hepatitisNew York Daily NewsHealth officials in Hawaii are asking stores to yank a fat-burning supplement after it was linked to multiple reports of liver failure and hepatitis, includ…
The high cost of battling hair loss – MSN Money
|
The high cost of battling hair loss
MSN Money Read on for more about your options and how much they’ll cost. Surgery. Hair transplant surgery involves removing a strip of scalp from the back of the head where hair growth is still thick. WebMD explains: Next, the surgeon divides the strip of … |
Cellmid awarded key European midkine antibodies patent, covers cancer and … – Proactive Investors USA & Canada
Proactive Investors USA & Canada |
Cellmid awarded key European midkine antibodies patent, covers cancer and …
Proactive Investors USA & Canada Maria Halasz, Cellmid’s chief executive officer, commented: “Having patents granted in Europe for our MK antibodies across such a wide array of diseases is a tremendous commercial outcome for Cellmid. “This patent gives Cellmid very clear exclusive … |
Cellmid awarded key European midkine antibodies patent, covers cancer and … – Proactive Investors UK
Proactive Investors UK |
Cellmid awarded key European midkine antibodies patent, covers cancer and …
Proactive Investors UK Maria Halasz, Cellmid’s chief executive officer, commented: “Having patents granted in Europe for our MK antibodies across such a wide array of diseases is a tremendous commercial outcome for Cellmid. “This patent gives Cellmid very clear exclusive … |
Living near airport bad for heart – Times of India
Times of IndiaLiving near airport bad for heartTimes of IndiaPrevious research has found links between living in a noisy environment and risk of high blood pressure, but few studies have looked at stroke, heart disease and circulatory diseases. The new…
After-Hours Stock Movers 10/9: (ACUR) (ENZN) (CHTP) Higher; (CTXS) (RT … – StreetInsider.com (subscription)
StreetInsider.com (subscription)After-Hours Stock Movers 10/9: (ACUR) (ENZN) (CHTP) Higher; (CTXS) (RT …StreetInsider.com (subscription)This DMC recommendation is based on a predefined interim analysis showing highly statistically significant efficac…
Gilead Ends Study of Leukemia Treatment Early After Positive Interim Results – NASDAQ
|
Gilead Ends Study of Leukemia Treatment Early After Positive Interim Results
NASDAQ It demonstrated ” highly statistically significant efficacy” in patients receiving the treatment receiving idelalisib plus rituximab compared with those receiving rituximab alone, the company said. The company said it told the Food and Drug … |